Clinical Trial Update: Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial comparing letrozole alone versus letrozole plus zoledronic acid as neoadjuvant endocrine therapy in postmenopausal breast cancer; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Neoplasms | Phase 4 | Status: TERMINATED | Results posted: 2012-04-25